Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Racine

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Annales De Biologie Clinique|February 5, 2009
[Uranium: properties and biological effects after internal contamination]M Souidi, E Tissandie, R Racine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2021
HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder CancerSarrah L Hasanali, Daley S Morera, Ronny R Racine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2020
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder CancerVinata B Lokeshwar, Daley S Morera, Sarrah L Hasanali, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Annales De Biologie Clinique|February 5, 2009
[Uranium: properties and biological effects after internal contamination]M Souidi, E Tissandie, R Racine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2021
HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder CancerSarrah L Hasanali, Daley S Morera, Ronny R Racine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2020
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder CancerVinata B Lokeshwar, Daley S Morera, Sarrah L Hasanali, et al.
Pageof 5